In addition to its effect on endothelial cells, VEGFR activation also stimulates osteoblast migration [13] and differentiation [14], suggesting that VEGF/VEGFR pathway may contribute to bone lesions in metastatic PC [15, 16]. The gene discussed is KDR; the disease is pachyonychia congenita.